PHS
ACOR

PFM Health Sciences’s Acorda Therapeutics ACOR Stock Holding History

PFM Health Sciences’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,718
Closed -$1.42M – 89
2020
Q1 		$1.42M Sell
12,718
-3,060
-19% -$602K 0.12% 60
2019
Q4 		$3.86M Sell
15,778
-2,441
-13% -$616K 0.18% 57
2019
Q3 		$6.28M Buy
+18,219
New +$9.9M 0.19% 63
2019
Q1 		– Sell
-9,239
Closed -$17.3M – 121
2018
Q4 		$17.3M Sell
9,239
-1,156
-11% -$2.52M 0.46% 61
2018
Q3 		$24.5M Sell
10,395
-7,611
-42% -$23.6M 0.36% 82
2018
Q2 		$62M Sell
18,006
-9,954
-36% -$30.5M 0.97% 36
2018
Q1 		$79.3M Sell
27,960
-803
-3% -$2.4M 1.61% 22
2017
Q4 		$74M Sell
28,763
-5,006
-15% -$14.2M 1.76% 19
2017
Q3 		$95.8M Buy
33,769
+12,201
+57% +$32.1M 1.88% 14
2017
Q2 		$51M Buy
+21,568
New +$42.7M 1.37% 29
2016
Q2 		– Sell
-3,986
Closed -$12.7M – 106
2016
Q1 		$12.7M Sell
3,986
-6,743
-63% -$28M 0.39% 62
2015
Q4 		$55.1M Buy
10,729
+3,115
+41% +$13.6M 1.67% 25
2015
Q3 		$24.2M Buy
7,614
+802
+12% +$3.11M 0.68% 46
2015
Q2 		$27.2M Buy
6,812
+2,935
+76% +$11.3M 0.69% 47
2015
Q1 		$15.5M Sell
3,877
-3,396
-47% -$15.6M 0.43% 63
2014
Q4 		$35.7M Sell
7,273
-2,944
-29% -$12.6M 0.83% 40
2014
Q3 		$41.5M Buy
+10,217
New +$38.3M 0.96% 32
2014
Q2 		– Sell
-6,030
Closed -$27.4M – 83
2014
Q1 		$27.4M Buy
+6,030
New +$24.4M 0.5% 50

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PFM Health Sciences's ACOR Position: Q2 2020 in Review

PFM Health Sciences sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 12,718 shares — an estimated $1.42M sold.

PFM Health Sciences first reported a position in ACOR in Q1 2014 and held it in 18 quarters. The position peaked at $95.8M in Q3 2017. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • PFM Health Sciences reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • PFM Health Sciences sold 12,718 Acorda Therapeutics shares in Q2 2020, an estimated $1.42M.
  • PFM Health Sciences first reported a position in Acorda Therapeutics in Q1 2014 and held it in 18 quarters.
  • PFM Health Sciences's Acorda Therapeutics position peaked at $95.8M in Q3 2017.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on PFM Health Sciences's 13F filing for Q2 2020, filed 14 Aug 2020.